In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs).
Highlights
The global In-situ Hybridization (ISH) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In situ hybridization is used to reveal the location of specific nucleic acid sequences on chromosomes or in tissues, a crucial step for understanding the organization, regulation, and function of genes. The key techniques currently in use include: in situ hybridization to mRNA with oligonucleotide and RNA probes (both radio-labelled and hapten-labelled); analysis with light and electron microscopes; whole mount in situ hybridization; double detection of RNAs and RNA plus protein; and fluorescent in situ hybridization to detect chromosomal sequences. DNA ISH can be used to determine the structure of chromosomes. Fluorescent DNA ISH (FISH) can, for example, be used in medical diagnostics to assess chromosomal integrity. RNA ISH (RNA in situ hybridization) is used to measure and localize RNAs (mRNAs, lncRNAs, and miRNAs) within tissue sections, cells, whole mounts, and circulating tumor cells (CTCs).
Report Scope
This report aims to provide a comprehensive presentation of the global market for In-situ Hybridization (ISH), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-situ Hybridization (ISH).
The In-situ Hybridization (ISH) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global In-situ Hybridization (ISH) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-situ Hybridization (ISH) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
ABBott Laboratories
F.Hoffmann-La Roche
Thermofisher Scientific
Merck
Agilent Technologies
Perkin Elmer
Danaher Corporation
Exiqon
Biogenex Laboratories
Advanced Cell Diagnostics
Bio SB
Segment by Type
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization
Segment by Application
Molecular Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-situ Hybridization (ISH) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-situ Hybridization (ISH) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Fluorescence In Situ Hybridization (FISH)
1.2.3 Chromogenic In Situ Hybridization
1.3 Market by Application
1.3.1 Global In-situ Hybridization (ISH) Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Molecular Diagnostic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Contract Research Organizations (CROs)
1.3.5 Academic & Research Institutions
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-situ Hybridization (ISH) Market Perspective (2018-2029)
2.2 In-situ Hybridization (ISH) Growth Trends by Region
2.2.1 Global In-situ Hybridization (ISH) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 In-situ Hybridization (ISH) Historic Market Size by Region (2018-2023)
2.2.3 In-situ Hybridization (ISH) Forecasted Market Size by Region (2024-2029)
2.3 In-situ Hybridization (ISH) Market Dynamics
2.3.1 In-situ Hybridization (ISH) Industry Trends
2.3.2 In-situ Hybridization (ISH) Market Drivers
2.3.3 In-situ Hybridization (ISH) Market Challenges
2.3.4 In-situ Hybridization (ISH) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-situ Hybridization (ISH) Players by Revenue
3.1.1 Global Top In-situ Hybridization (ISH) Players by Revenue (2018-2023)
3.1.2 Global In-situ Hybridization (ISH) Revenue Market Share by Players (2018-2023)
3.2 Global In-situ Hybridization (ISH) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-situ Hybridization (ISH) Revenue
3.4 Global In-situ Hybridization (ISH) Market Concentration Ratio
3.4.1 Global In-situ Hybridization (ISH) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-situ Hybridization (ISH) Revenue in 2022
3.5 In-situ Hybridization (ISH) Key Players Head office and Area Served
3.6 Key Players In-situ Hybridization (ISH) Product Solution and Service
3.7 Date of Enter into In-situ Hybridization (ISH) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-situ Hybridization (ISH) Breakdown Data by Type
4.1 Global In-situ Hybridization (ISH) Historic Market Size by Type (2018-2023)
4.2 Global In-situ Hybridization (ISH) Forecasted Market Size by Type (2024-2029)
5 In-situ Hybridization (ISH) Breakdown Data by Application
5.1 Global In-situ Hybridization (ISH) Historic Market Size by Application (2018-2023)
5.2 Global In-situ Hybridization (ISH) Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America In-situ Hybridization (ISH) Market Size (2018-2029)
6.2 North America In-situ Hybridization (ISH) Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America In-situ Hybridization (ISH) Market Size by Country (2018-2023)
6.4 North America In-situ Hybridization (ISH) Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-situ Hybridization (ISH) Market Size (2018-2029)
7.2 Europe In-situ Hybridization (ISH) Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe In-situ Hybridization (ISH) Market Size by Country (2018-2023)
7.4 Europe In-situ Hybridization (ISH) Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-situ Hybridization (ISH) Market Size (2018-2029)
8.2 Asia-Pacific In-situ Hybridization (ISH) Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific In-situ Hybridization (ISH) Market Size by Region (2018-2023)
8.4 Asia-Pacific In-situ Hybridization (ISH) Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-situ Hybridization (ISH) Market Size (2018-2029)
9.2 Latin America In-situ Hybridization (ISH) Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America In-situ Hybridization (ISH) Market Size by Country (2018-2023)
9.4 Latin America In-situ Hybridization (ISH) Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-situ Hybridization (ISH) Market Size (2018-2029)
10.2 Middle East & Africa In-situ Hybridization (ISH) Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa In-situ Hybridization (ISH) Market Size by Country (2018-2023)
10.4 Middle East & Africa In-situ Hybridization (ISH) Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ABBott Laboratories
11.1.1 ABBott Laboratories Company Detail
11.1.2 ABBott Laboratories Business Overview
11.1.3 ABBott Laboratories In-situ Hybridization (ISH) Introduction
11.1.4 ABBott Laboratories Revenue in In-situ Hybridization (ISH) Business (2018-2023)
11.1.5 ABBott Laboratories Recent Development
11.2 F.Hoffmann-La Roche
11.2.1 F.Hoffmann-La Roche Company Detail
11.2.2 F.Hoffmann-La Roche Business Overview
11.2.3 F.Hoffmann-La Roche In-situ Hybridization (ISH) Introduction
11.2.4 F.Hoffmann-La Roche Revenue in In-situ Hybridization (ISH) Business (2018-2023)
11.2.5 F.Hoffmann-La Roche Recent Development
11.3 Thermofisher Scientific
11.3.1 Thermofisher Scientific Company Detail
11.3.2 Thermofisher Scientific Business Overview
11.3.3 Thermofisher Scientific In-situ Hybridization (ISH) Introduction
11.3.4 Thermofisher Scientific Revenue in In-situ Hybridization (ISH) Business (2018-2023)
11.3.5 Thermofisher Scientific Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck In-situ Hybridization (ISH) Introduction
11.4.4 Merck Revenue in In-situ Hybridization (ISH) Business (2018-2023)
11.4.5 Merck Recent Development
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Detail
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies In-situ Hybridization (ISH) Introduction
11.5.4 Agilent Technologies Revenue in In-situ Hybridization (ISH) Business (2018-2023)
11.5.5 Agilent Technologies Recent Development
11.6 Perkin Elmer
11.6.1 Perkin Elmer Company Detail
11.6.2 Perkin Elmer Business Overview
11.6.3 Perkin Elmer In-situ Hybridization (ISH) Introduction
11.6.4 Perkin Elmer Revenue in In-situ Hybridization (ISH) Business (2018-2023)
11.6.5 Perkin Elmer Recent Development
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Detail
11.7.2 Danaher Corporation Business Overview
11.7.3 Danaher Corporation In-situ Hybridization (ISH) Introduction
11.7.4 Danaher Corporation Revenue in In-situ Hybridization (ISH) Business (2018-2023)
11.7.5 Danaher Corporation Recent Development
11.8 Exiqon
11.8.1 Exiqon Company Detail
11.8.2 Exiqon Business Overview
11.8.3 Exiqon In-situ Hybridization (ISH) Introduction
11.8.4 Exiqon Revenue in In-situ Hybridization (ISH) Business (2018-2023)
11.8.5 Exiqon Recent Development
11.9 Biogenex Laboratories
11.9.1 Biogenex Laboratories Company Detail
11.9.2 Biogenex Laboratories Business Overview
11.9.3 Biogenex Laboratories In-situ Hybridization (ISH) Introduction
11.9.4 Biogenex Laboratories Revenue in In-situ Hybridization (ISH) Business (2018-2023)
11.9.5 Biogenex Laboratories Recent Development
11.10 Advanced Cell Diagnostics
11.10.1 Advanced Cell Diagnostics Company Detail
11.10.2 Advanced Cell Diagnostics Business Overview
11.10.3 Advanced Cell Diagnostics In-situ Hybridization (ISH) Introduction
11.10.4 Advanced Cell Diagnostics Revenue in In-situ Hybridization (ISH) Business (2018-2023)
11.10.5 Advanced Cell Diagnostics Recent Development
11.11 Bio SB
11.11.1 Bio SB Company Detail
11.11.2 Bio SB Business Overview
11.11.3 Bio SB In-situ Hybridization (ISH) Introduction
11.11.4 Bio SB Revenue in In-situ Hybridization (ISH) Business (2018-2023)
11.11.5 Bio SB Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
ABBott Laboratories
F.Hoffmann-La Roche
Thermofisher Scientific
Merck
Agilent Technologies
Perkin Elmer
Danaher Corporation
Exiqon
Biogenex Laboratories
Advanced Cell Diagnostics
Bio SB
Ìý
Ìý
*If Applicable.